New regimen for patients with lymphoma prolongs PFS by up to 28 months

Share This Post

12 Yue days, a study “The Lancet” published online, for CD30 -positive outer peripheral -cell lymphoma patients, this rituximab, cyclophosphamide, doxorubicin and prednisone ( A + CHP ) Better than cyclophosphamide, doxorubicin, vincristine and prednisone ( CHOP ).

Steven Horwitz , MD, from the Memorial Sloan Kettering Cancer Center in New York City and colleagues conducted a double-blind, placebo-controlled, active-control phase 3 study involving 452 patients from 132 locations in 17 countries . These patients CD30- positive peripheral T- cell lymphoma without prior treatment . Patients with 1 : 1 random allocation ratio, accepts A + CHP or of CHOP , sustained 6 , or . 8 th 21 is day cycle.

The researchers found that the median progression-free survival ( PFS ) of the A + CHP group and the CHOP group were 48.2 and 20.8 months, respectively. The incidence of side effects was similar between the two groups, including febrile neutropenia ( 18 % and 15 %, respectively) and peripheral neuropathy ( 52 % and 55 %, respectively). Fatal adverse events occurred in 3 % and 4 % of patients, respectively.

In the CHP to add this cetuximab can improve progression-free and overall survival without increasing toxicity, the study supports the A + CHP for many CD30 positive outer peripheral T new standard treatment for lymphoma patients.

Website |  + posts

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Nutritional Advice for Liver Transplant Patients Pre-and Post-Surgery
Liver cancer

Nutritional Advice for Liver Transplant Patients: Pre-and Post-Surgery

Liver transplantation is a sophisticated procedure, and nutrition plays an important role both in pre-transplant preparation and post-transplant recovery. Patients should emphasize keeping protein levels up, eating enough calories, and restricting sodium before surgery to prevent fluid retention. Following surgery, a well-balanced diet high in proteins, vitamins, and minerals supports healing and avoids complications. Long-term dietary measures are responsible for the success of the transplant and general well-being.

Immunotherapy for bladder cancer
Bladder cancer

Immunotherapy for bladder cancer

Immunotherapy is revolutionizing bladder cancer treatment by harnessing the immune system to fight cancer cells. Checkpoint inhibitors like pembrolizumab and nivolumab have shown promising results in advanced cases, while BCG therapy remains effective for non-muscle-invasive bladder cancer. Emerging treatments, including gene therapy and experimental drugs like cretostimogene, offer new hope. Ongoing research and clinical trials continue to refine these therapies, enhancing outcomes for patients with bladder cancer.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

CancerFax is the most trusted online platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies.

Send your medical reports and get a free analysis.

🌟 Join us in the fight against cancer! 🌟

Привет,

CancerFax — это самая надежная онлайн-платформа, призванная предоставить людям, столкнувшимся с раком на поздних стадиях, доступ к революционным клеточным методам лечения.

Отправьте свои медицинские заключения и получите бесплатный анализ.

🌟 Присоединяйтесь к нам в борьбе с раком! 🌟